Literature DB >> 3006339

Visualisation, by immunocytochemistry, of p53 at the plasma membrane of both nontransformed and SV40-transformed cells.

J Milner, A Cook.   

Abstract

The cellular protein p53 normally functions in the control of cell proliferation; but, when expressed abnormally p53 also contributes towards the process of cell transformation. The functioning of p53 is thought to involve interaction with specific cellular targets and, in SV40- and other transformed cells, p53 is located in the nucleus: thus p53 may function via interacting with specific nuclear components. In addition, there is indirect evidence that in SV40-transformed cells p53 is also associated with the plasma membrane; however, this is not evident in cells stained by immunofluorescence. We have sought to obtain direct evidence for p53 at the plasma membrane by staining with a very sensitive immunocytochemical procedure. We have compared SV40-transformed BALB 3T3 cells with BALB 3T3, NIH 3T3, and NIH 3T3 transfected with v-mos provirus. The last cell line is tumorogenic. We found direct evidence for p53 at the plasma membrane for each cell line. In nontransformed and SV40-transformed cells the association of p53 with the plasma membrane was restricted to the period of mitosis. These results indicate that association of p53 with the plasma membrane is a normal, rather than a transformation-related phenomenon, and is temporally linked to the period of mitosis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3006339     DOI: 10.1016/0042-6822(86)90286-2

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  2 in total

1.  Integration of Friend murine leukemia virus into both alleles of the p53 oncogene in an erythroleukemic cell line.

Authors:  G G Hicks; M Mowat
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

2.  Potentials and capabilities of the Extracellular Vesicle (EV) Array.

Authors:  Malene Møller Jørgensen; Rikke Bæk; Kim Varming
Journal:  J Extracell Vesicles       Date:  2015-04-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.